Pharmafile - Medical Communications News

Ian Read has seen his total compensation cut from a sum of $27.9 million in 2018 to $19.5 million this year.

Richard Francis is set to step down his role as Chief Executive of Novartis’ generics arm Sandoz after five years’ in the role, citing “personal...

A California jury has ordered American healthcare conglomerate Johnson & Johnson to pay more than $29 million to a woman with mesothelioma who...

Following the surprise resignation of current FDA Commissioner Dr Scott Gottlieb a week earlier, Dr Norman ‘Ned’ Sharpless, Director of the...

The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to pharmaceutical industry...

There has been a sharp increase in cases of measles across Greater Manchester, Public Health England has warned, following increasingly frequent...

- FDA Commissioner Scott Gottlieb announces resignation - London man becomes second in world to be cured of HIV - Indian government set to colour...

A long acting, injectable two drug regimen developed by Pfizer and GSK joint venture ViiV Healthcare and J&J subsidiary Jannsen, has similar...

Roche has announced the approval of the European Commission for its PD-L1 inhibitor Tecentriq (atezolizumab) when used in combination with Avastin...

Dutch pharmacists have vowed to circumvent rules enforcing Novartis’ market exclusivity for radioactive cancer drug Lutathera.